PhRMA's Contributions to The Fight Against Chronic Diseases

04.08.13 | By

According to the Kaiser Family Foundation, health care expenditures in the United States approached $2.6 trillion in 2010, over ten times the $256 billion spent in 1980. The expectation this year: Americans will spend $2.9 trillion on health care. And federal, state and local government agencies are in overdrive to find the best ways to reduce costs and still maintain quality patient care. That commitment is shared by (PhRMA) and its member companies.

Direct to Consumer Advertising Principles – Annual Certifications

Code on Interactions With Health Care Professionals

  • The Pharmaceutical Research and Manufacturers of America (PhRMA) represents research-based pharmaceutical and biotechnology companies. Our members develop and market new medicines to enable patients to live longer and healthier lives.

Learn More About Medicines in Development for HIV/AIDS

In the United States, more than 1.1 million people are living with HIV and 15.8 percent of those are unaware they are infected, according to the U.S. Centers for Disease Control and Prevention (CDC). However, multiple medical advancements have taken place since 1981, when the CDC identified the first five cases of HIV/AIDS.

Code on Business Ethics

This Week #PhRMA13 Convenes a New Conversation on Research, Progress and Hope

04.08.13 | By

In just a few days, health care industry leaders, biomedical professionals and patients from across the country will convene at #PhRMA13 in San Diego to discuss the future of medicine and share ideas as to how we can all make PhRMA's mission of research, progress and hope an ongoing reality. The panels throughout the meeting will focus on this mission.

Questions and Answers for Peer Speakers Program for Health Care Professionals

Why do biopharmaceutical companies sponsor peer speaker programs for health care professionals?

Doctors and other healthcare professionals with real-world clinical experience in specific therapeutic areas are uniquely qualified to educate and inform their peers about the medicines they prescribe. While physicians consult many sources for information, it can be a challenge for them to juggle the demands of clinical practice with the need to stay up-to-date with the latest science and FDA-approved treatment options.


Read speeches, public addresses and congressional testimony by PhRMA CEO and President John Castellani and other pharmaceutical industry leaders. Click on any of the links below to read one of the speeches.

John J. Castellani 2014 Annual Meeting Remarks

Week In Review: When Minor Discoveries Make All The Difference

04.06.13 | By

Have you ever considered what it took to develop medicines, like aspirin, that we use regularly? It was far from an overnight discovery. The medicines we sometimes take for granted are the result of decades of intense research and development.

Press Room

PhRMApedia's Press Room provides the most recent press releases. Search PhRMApedia for additional press releases.


Subscribe to RSS - Opinion